Lacticaseicin 30 and Colistin as a Promising Antibiotic Formulation against Gram-Negative β-Lactamase-Producing Strains and Colistin-Resistant Strains

Lacticaseicin 30 and Colistin as a Promising Antibiotic Formulation against Gram-Negative β-Lactamase-Producing Strains and Colistin-Resistant Strains

Antimicrobial resistance is a global health concern across the world and it is foreseen to swell if no actions are taken now. To help curbing this well announced crisis different strategies are announced, and these include the use of antimicrobial peptides (AMP), which are remarkable molecules known...

Full description

Bibliographic Details
Main Authors: Désiré Madi-Moussa, Yanath Belguesmia, Audrey Charlet, Djamel Drider, Françoise Coucheney
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Antibiotics
Subjects:
lacticaseicin 30
colistin
Gram-negative clinical strains
beta-lactamase
synergistic activities
RT-qPCR
Online Access:https://www.mdpi.com/2079-6382/11/1/20

Internet

https://www.mdpi.com/2079-6382/11/1/20

Similar Items